DHSC FOI-1712285 response 20 July 2026
JBD request: 19 June 2026 · JBD filing reference: FoI_1C1d · Authority case reference: FOI-1712285
- JBD request date
- 19 June 2026
- JBD internal filing reference
- FoI_1C1d
- Authority case reference
- FOI-1712285
Open or download the complete original
DHSC assessment requests
- DHSC reply to the original design and implementation request, 25 February 2026
- DHSC reply to the May patient-assessment request, 8 June 2026
- DHSC FOI-1712285 response 20 July 2026
Document text
The complete original retains the page layout and any redactions.
PDF page 1
Freedom of Information Team Department of Health and Social Care 39 Victoria Street London SW1H 0EU www.gov.uk/dhsc Mr Peter Lindsay By email to: pete.lindsay@justicebydesign.org.uk 20 July 2026 Dear Mr Lindsay, Freedom of Information Request Reference FOI-1712285 Thank you for your request dated 19 June to the Department of Health and Social Care (DHSC), a copy of which can be found in the accompanying annex. Your request has been handled under the Freedom of Information Act 2000 (FOIA). DHSC holds information relevant to your request. However, to provide the information as it is currently framed would exceed the appropriate cost limit set out in the FOIA. Section 12(1) of the FOIA means public authorities are not obliged to comply with a request for information if they estimate the cost of complying would exceed the appropriate limit. The appropriate limit for DHSC is set at £600, which represents the cost of one person spending 24 working hours determining whether we hold the information, and then locating, retrieving and extracting the information. Although we cannot answer your request at the moment, we may be able to answer a refined request within the cost limit. You may wish to consider, for example, substantially reducing the following. • the time frame • the number of questions and or • the type of information or type of documents. Please be aware that we cannot guarantee at this stage that a refined request would fall within the FOIA cost limit, or that other exemptions will not apply. We have additional information which we are providing to you on a discretionary basis. This information is outside the scope of your request and is therefore not subject to internal review. DHSC would also like to draw your attention to paragraph 7.17 of the Home Office Explanatory Memorandum to The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A link to the document is available at: The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 - Explanatory Memorandum.
PDF page 2
This states: "Cannabis-based products for medicinal use cannot be smoked Due to the harms associated with smoking, the ACMD [Advisory Council on the Misuse of Drugs] recommended ensuring that any prescription of cannabis-based products for medicinal use should not include smoking as a route of administration. There was also a concern that permitting smoking of cannabis-based products for medicinal use would make it significantly more difficult to enforce existing offences on the recreational use of cannabis. This instrument therefore continues to prohibit smoking of cannabis, by banning the administration of cannabis-based products for medicinal use in humans by smoking." Whilst we recognise that this does not directly address your request, in terms of what informed the statement attributed to DHSC colleagues in the Home Office submission of 13 September 2019, the Explanatory Memorandum shows the legislator took advice from the ACMD - the main clinical and expert advisory body on matters relating to controlled drugs - and that the ban on smoking was based on two factors: the known harms of smoking and the enforcement difficulty in distinguishing prescribed from recreational cannabis. This is consistent with the information set out in the Home Office submission of 13 September 2018 (Annex A of your request) If you are not satisfied with the handling of your request, you can request we undertake an internal review. If doing so, it would be helpful for you to be explicit which areas of the Freedom of Information response you consider dissatisfactory. Complaints to us should be sent to freedomofinformation@dhsc.gov.uk or to the address at the top of this letter and be submitted within 40 working days of the date of this letter. Please remember to quote the reference number above in any future communication. If you are not content with the outcome of your internal review, you may complain directly to the Information Commissioner’s Office (ICO). Generally, the ICO cannot make a decision unless you have already complained to us about our original response and received our response to your complaint and, if applicable, our internal review decision. You should raise your concerns with the ICO within six weeks of your last substantive contact with us. Guidance on contacting the ICO can be found at https://ico.org.uk/global/contact-us and information about making a complaint can be found at https://ico.org.uk/make-a-complaint. Yours sincerely, Freedom of Information Team freedomofinformation@dhsc.gov.uk
PDF page 3
FoI_1C1d 19/06/2026 FOI_1C1d – DHSC 19 June 2026 Freedom of Information Request – Refined Request Following FOI-1704324 This request is made under the Freedom of Information Act 2000. This request follows the Department's response to FOI-1704324 (Annex B). It is intended to refine the scope of the earlier request in accordance with the advice provided under section 16 FOIA. Background Annex A is the Home Office ministerial submission entitled: "Cannabis: Options on Definition of Cannabis Based Medicinal Products" dated 13 September 2018. Annex A states: "DHSC colleagues assess the likelihood that specialist clinicians prescribing cannabis for the purposes of smoking to be extremely low" and further concludes that the circumstances in which cannabis could legitimately be prescribed for smoking would be very narrow. The present request is confined to the recorded basis of those specific assessments. Requested Information 1. Basis of assessment Please provide the recorded information that informed the statement reproduced in Annex A that: "DHSC colleagues assess the likelihood that specialist clinicians prescribing cannabis for the purposes of smoking to be extremely low." 2. Basis of conclusion Please provide the recorded information that informed the conclusion reproduced in Annex A that the circumstances in which cannabis could legitimately be prescribed for smoking would be very narrow. Annex A
PDF page 4
FoI_1C1d 19/06/2026 3. Source categories Please identify whether the assessments referred to in Questions 1 and 2 were informed by: • clinical advice; • clinician engagement; • expert advisory input; • ACMD engagement; • literature review; • policy analysis; • equality analysis; or • any other recorded source. 4. Identification of source material Please provide the records identifying the source or sources relied upon in reaching the assessments referred to in Questions 1 and 2. If the assessments were not based upon recorded information, please confirm this. Yours sincerely, Pete Lindsay Justice by Design